Why the study?
Does intraoperative elevation of high-sensitivity cardiac troponin I (hs-cTnI) predict 90-day all-cause mortality in adult patients undergoing liver transplantation when stratified by preoperative hs-cTnI levels?
Does intraoperative elevation of high-sensitivity cardiac troponin I (hs-cTnI) predict 90-day all-cause mortality in adult patients undergoing liver transplantation when stratified by preoperative hs-cTnI levels?
New-onset intraoperative hs-cTnI elevations are common during liver transplantation and linked to anemia, hypercoagulability, and inflammation, but they only predict 90-day mortality in patients who already have elevated preoperative troponin levels.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: